Nowadays, Topoisomerase 1 (Top1) enzyme is an important target of anti-tumor drugs, and Top1 inhibitors are widely used in clinical practice, the main chemotherapeutic drugs targeting Top1 were camptothecin (CPT) and its derivatives. This evidence concerns the gene TOP1 and neoplasm.